Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
The American Journal of Cardiology|August 30, 2008
Drug-eluting stents versus bare metal stents for narrowing in saphenous vein graftsTeruo Okabe, Joseph Lindsay, Ashesh N Buch, et al.Cell Death & Disease|June 14, 2019
miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shockZhenyi Xue, Qing Xi, Hongkun Liu, et al.The American Journal of Cardiology|August 19, 2007
Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deploymentTeruo Okabe, Gary S Mintz, Ashesh N Buch, et al.The American Journal of Cardiology|July 22, 2008
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry)Probal Roy, Laurent Bonello, Axel de Labriolle, et al.The American Journal of Cardiology|November 11, 2008
Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary interventionLaurent Bonello, Gilles Lemesle, Axel De Labriolle, et al.The American Journal of Cardiology|July 26, 2011
Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulationRafael Romaguera, Gabriel Sardi, Ana Laynez-Carnicero, et al.The American Journal of Cardiology|August 30, 2008
Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndromeLaurent Bonello, Axel De Labriolle, Probal Roy, et al.American Heart Journal|December 5, 2009
The clinical significance of hematocrit values before and after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Sara D Collins, et al.European Heart Journal|June 14, 2008
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stentsProbal Roy, Daniel H Steinberg, Steven J Sushinsky, et al.The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.Pageof 19